FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.
Even mild COVID is hard on the brain
New study results suggest a severe pattern of changes in how the brain communicates as well as its structure in people with anxiety and depression...
Prone positioning curbs need for intubation in nonintubated COVID-19 patients
The use of so-called “awake prone positioning” has been common since the early days of the COVID-19 pandemic.
Metformin linked to reductions in COVID-19 viral load
Key questions the findings raise include whether the results correlate with clinical outcomes or transmission, and whether the findings are...
COVID update: ASH experts discuss thrombosis, immunity
Presidential symposium plumbs the mysteries of an “extraordinarily stealthy” virus, considers postvaccine blood clots.
Liver disease-related deaths rise during pandemic
“The increasing trend in mortality rates for ALD and NAFLD has been quite alarming, with disparities in age, race, and ethnicity.”
New research confirms recommendations on COVID-19 boosters in MS
“Even MS patients whose B cells were depleted from circulation with ocrelizumab can mount immune responses to COVID-19 vaccines.”
Updated Moderna booster shows greater activity against COVID in adults
Additionally, no new safety concerns emerged.
More data suggest preexisting statin use improves COVID outcomes
The researchers saw lower mortality and clinical severity among statin users.
Research fails to justify post-COVID-19 wave of new-onset parkinsonism
While cases have been reported, current data do not yet justify the concept of a post–COVID-19 parkinsonism wave.